VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IRMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IRMDIRadimed Corporation
$100.24$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIRMDQuarterly Financials

IRadimed Corporation (IRMD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

IRadimed Corporation (IRMD) quarterly income statement — complete revenue, gross profit & net income history

IRMD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue21.98M22.69M21.2M20.41M19.51M19.39M18.33M17.93M17.6M17.45M16.5M16.13M15.48M14.86M13.41M12.72M12.31M11.87M10.91M9.81M
Revenue Growth %12.65%17.03%15.69%13.84%10.87%11.1%11.04%11.15%13.72%17.42%23.1%26.8%25.7%25.19%22.92%29.67%33.46%38.93%41.67%44.38%
Cost of Goods Sold5.17M5.66M4.71M4.45M4.67M4.63M4.13M3.92M4.21M4.04M3.67M3.94M3.75M3.64M2.86M2.58M2.93M2.62M2.5M2.48M
COGS % of Revenue23.5%24.94%22.2%21.83%23.92%23.87%22.56%21.86%23.93%23.14%22.22%24.45%24.26%24.51%21.37%20.29%23.81%22.09%22.94%25.26%
Gross Profit16.81M17.03M16.49M15.95M14.84M14.76M14.19M14.01M13.39M13.41M12.84M12.19M11.72M11.22M10.54M10.14M9.38M9.25M8.41M7.33M
Gross Margin %76.5%75.06%77.8%78.17%76.08%76.13%77.44%78.14%76.07%76.86%77.78%75.55%75.74%75.49%78.63%79.71%76.19%77.91%77.06%74.74%
Gross Profit Growth %13.28%15.39%16.23%13.89%10.87%10.05%10.55%14.96%14.22%19.54%21.77%20.19%24.97%21.3%25.43%38.29%32.81%43.64%46.41%48.73%
Operating Expenses9.58M9.94M9.66M9.17M9.41M8.96M8.4M8.38M8.64M8.25M6.93M7.22M7.71M6.97M6.41M5.97M6.3M6.14M5.32M5.49M
OpEx % of Revenue43.57%43.8%45.56%44.92%48.24%46.21%45.85%46.75%49.09%47.29%42%44.78%49.85%46.87%47.81%46.95%51.21%51.72%48.76%55.94%
Selling, General & Admin8.62M9.14M8.99M8.29M8.79M8.39M7.76M7.58M7.82M7.6M6.48M6.26M6.92M6.36M5.92M5.31M5.79M5.65M4.84M5.03M
SG&A % of Revenue39.22%40.27%42.38%40.62%45.04%43.27%42.36%42.29%44.43%43.56%39.26%38.82%44.72%42.8%44.15%41.74%47%47.55%44.36%51.32%
Research & Development956K799K674.36K877.36K624.25K569.99K639.47K801.13K821K650.43K452.56K961.95K793.72K604.74K491.64K662.6K519.1K494.85K480.7K453.68K
R&D % of Revenue4.35%3.52%3.18%4.3%3.2%2.94%3.49%4.47%4.67%3.73%2.74%5.96%5.13%4.07%3.67%5.21%4.22%4.17%4.41%4.62%
Other Operating Expenses00000000000010000000
Operating Income7.24M7.09M6.83M6.79M5.43M5.8M5.79M5.63M4.75M5.16M5.91M4.96M4.01M4.25M4.13M4.17M3.07M3.11M3.09M1.84M
Operating Margin %32.93%31.26%32.23%33.26%27.84%29.91%31.59%31.39%26.98%29.57%35.78%30.77%25.89%28.62%30.82%32.75%24.98%26.19%28.3%18.8%
Operating Income Growth %33.24%22.31%18.04%20.63%14.39%12.41%-1.97%13.38%18.49%21.3%42.91%19.12%30.32%36.8%33.87%125.93%73.04%377.64%293.35%162.96%
EBITDA7.24M7.71M7.22M7.38M5.63M6M5.99M5.83M4.97M5.37M6.1M5.15M4.19M3.56M4.57M4.66M3.51M3.5M3.43M2.19M
EBITDA Margin %32.93%33.97%34.04%36.16%28.83%30.92%32.67%32.5%28.27%30.74%36.93%31.93%27.07%23.96%34.07%36.64%28.5%29.45%31.42%22.35%
EBITDA Growth %28.64%28.57%20.56%26.68%13.09%11.74%-1.78%13.12%18.73%50.67%33.44%10.51%19.41%1.85%33.29%112.58%66.39%253.13%207.15%184.16%
D&A (Non-Cash Add-back)0614K383.72K592.45K194.12K194.87K197.57K199.13K226.09K205.38K189.9K187.36K182.55K-692.9K435.48K494.18K433.93K386.6K340.13K348.3K
EBIT7.24M7.09M7.3M7.33M5.43M6.34M5.79M5.63M4.75M5.16M5.91M4.96M4.01M4.25M4.13M4.17M3.07M3.11M3.09M1.84M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense532K697K463.98K539.25K513.97K544.16K629.2K642.22K495.15K521.81K503.19K335.39K342.41K449.73K105.18K13.1K-14.91K3.93K7.14K13.2K
Pretax Income7.77M7.79M7.3M7.33M5.95M6.34M6.42M6.27M5.24M5.68M6.41M5.3M4.35M4.7M4.24M4.18M3.06M3.11M3.09M1.86M
Pretax Margin %35.35%34.33%34.42%35.9%30.47%32.72%35.02%34.97%29.8%32.56%38.83%32.85%28.11%31.64%31.61%32.86%24.86%26.22%28.37%18.93%
Income Tax1.95M1.35M1.72M1.55M1.26M1.2M1.37M1.37M1.11M1.14M1.34M1.12M943.59K1.03M810.38K938.63K573.29K-779.17K517.77K387.73K
Effective Tax Rate %25.11%17.31%23.58%21.2%21.16%18.88%21.33%21.82%21.11%20.1%20.93%21.11%21.69%21.9%19.12%22.46%18.74%-25.03%16.73%20.87%
Net Income5.82M6.44M5.58M5.77M4.69M5.15M5.05M4.9M4.14M4.54M5.07M4.18M3.41M3.67M3.43M3.24M2.49M3.89M2.58M1.47M
Net Margin %26.47%28.39%26.3%28.29%24.02%26.54%27.55%27.34%23.51%26.01%30.7%25.91%22.01%24.72%25.56%25.48%20.2%32.79%23.62%14.98%
Net Income Growth %24.12%25.17%10.44%17.81%13.32%13.37%-0.35%17.26%21.45%23.58%47.86%28.97%36.97%-5.63%33.03%120.53%79.31%510.7%139.73%169.58%
Net Income (Continuing)5.82M6.44M5.58M5.77M4.69M5.15M5.05M4.9M4.14M4.54M5.07M4.18M3.41M3.67M3.43M3.24M2.49M3.89M2.58M1.47M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.450.500.430.450.370.400.400.380.320.360.400.330.270.290.270.260.200.310.200.12
EPS Growth %21.62%25%7.5%18.42%15.63%11.11%0%15.15%18.52%24.14%48.15%26.92%35%-6.45%35%116.67%81.82%520%122.22%170.59%
EPS (Basic)0.460.510.440.450.370.410.400.390.330.360.400.330.270.290.270.260.200.310.210.12
Diluted Shares Outstanding12.87M12.88M12.86M12.83M12.83M12.78M12.78M12.76M12.75M12.74M12.74M12.72M12.69M12.63M12.63M12.63M12.66M12.63M12.6M12.55M
Basic Shares Outstanding12.78M12.74M12.72M12.72M12.71M12.68M12.67M12.66M12.66M12.62M12.6M12.6M12.59M12.57M12.56M12.56M12.55M12.43M12.33M12.31M
Dividend Payout Ratio-132.79%38.78%37.44%46.11%36.94%37.64%38.76%192.82%---388.22%---505.05%---